Stay updated on Safety of Pembrolizumab Combo in Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the Safety of Pembrolizumab Combo in Advanced Melanoma Clinical Trial page.

Latest updates to the Safety of Pembrolizumab Combo in Advanced Melanoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedA new revision label 'Revision: v3.3.3' was added, and the 'HHS Vulnerability Disclosure' link along with the older 'Revision: v3.3.2' label were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedA new site revision entry, v3.3.2, has been added to the page history. The previous revision entry, v3.2.0, has been removed.SummaryDifference0.1%

- Check49 days agoChange DetectedA non-critical operating-status notice about government funding was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check70 days agoChange DetectedOld and new screenshots show a UI revision of the Record History page with no substantive changes to the study record, and no core page content is altered; to avoid alerts from small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check93 days agoChange Detected- Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.SummaryDifference9%

- Check100 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.2%

Stay in the know with updates to Safety of Pembrolizumab Combo in Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Pembrolizumab Combo in Advanced Melanoma Clinical Trial page.